A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

Inclusion Criteria

• •Patients must be treated with maintenance hemodialysis and prescribed a phosphate binder.
• •A controlled serum phosphorus.
• •Constant dose of concomitant medications.
• •Women of child bearing potential must be practicing an acceptable form of birth control (i.e. double barrier method - intrauterine device plus condom, spermicidal gel plus condom). All female patients must have a negative pregnancy test at screening in order to be eligible to participate in the study.